Dominic P. Mcgovern
Cambridge, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Incorporating frailty and disease severity into treatment decisions for older patients with ANCA-associated vasculitis.
Journal: Rheumatology (Oxford, England)
Published: August 15, 2025
Spatial profiling of giant cell arteritis tissues reveals immune heterogeneity and potential predictors of glucocorticoid response.
Journal: Annals of the rheumatic diseases
Published: February 05, 2025
The Expanding Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Armamentarium.
Journal: Drugs
Published: December 15, 2024
Study protocol for a randomised, phase II, double-blind, experimental medicine study of obinutuzumab versus rituximab in ANCA-associated vasculitis: ObiVas.
Journal: BMJ open
Published: July 17, 2024
Profiling immune cell tissue niches in the spatial -omics era.
Journal: The Journal of allergy and clinical immunology
Published: July 15, 2024
The Improved Kidney Risk Score in ANCA-Associated Vasculitis for Clinical Practice and Trials.
Journal: Journal of the American Society of Nephrology : JASN
Published: August 04, 2023
Outcomes in ANCA-Associated Vasculitis in Scotland: Validation of the Renal Risk Score in a Complete National Cohort.
Journal: Kidney international reports
Published: December 20, 2022
Avacopan for ANCA-associated vasculitis - information for prescribers.
Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
Published: November 16, 2022
Long-term outcomes in elderly patients with ANCA-associated vasculitis.
Journal: Rheumatology (Oxford, England)
Published: April 11, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026